Trial intelligence / Profile preview

Doxepin cream for knee osteoarthritis pain

IRCT20161204031229N7Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
Apr 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of doxepin in knee osteoarthritis (OA), sponsored by Iran University of Medical Sciences. Started Apr 2022; status: completed.

02

Drugs

doxepin
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on IRCT20161204031229N7.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20161204031229N7.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call